Rocket Pharmaceuticals, Inc.
DE ˙ DB ˙ US77313F1066
2,44 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:9IP1 / Rocket Pharmaceuticals, Inc.
InstitutionStifel Financial Corp
Latest Disclosed Ownership34,356 shares
Latest Disclosed Value $ 122,994
Stifel Financial Corp reports 1.84% decrease in ownership of 9IP1 / Rocket Pharmaceuticals, Inc.

On May 12, 2026 - Stifel Financial Corp filed a 13F-HR form disclosing ownership of 34,356 shares of Rocket Pharmaceuticals, Inc. (DE:9IP1) valued at $96,712 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 35,000 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of -1.84% during the quarter. The current value of the position is $83,829 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 34,356 -644 -1.84 123 0.00 0.0000
2026-02-13 2025-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 35,000 -4,200 -10.71 123 -3.94 0.0001
2025-11-12 2025-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 39,200 22,850 139.76 128 217.50 0.0001
2025-08-14 2025-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 16,350 -2,656 -13.97 40 -68.25 0.0000
2025-05-14 2025-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 19,006 -1,457 -7.12 127 -50.97 0.0001
2025-02-13 2024-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 20,463 370 1.84 257 -30.73 0.0003
2024-11-14 2024-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 20,093 -490 -2.38 371 -16.25 0.0004
2024-08-13 2024-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 20,583 537 2.68 443 -17.96 0.0005
2024-05-14 2024-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 20,046 709 3.67 540 -6.74 0.0006
2024-02-12 2023-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 19,337 -4,213 -17.89 580 20.12 0.0007
2023-11-13 2023-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 23,550 2,034 9.45 483 12.88 0.0007
2023-08-14 2023-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 21,516 2,436 12.77 428 30.98 0.0006
2023-05-12 2023-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 19,080 2,548 15.41 327 0.93 0.0005
2023-02-13 2022-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 16,532 2,571 18.42 324 44.84 0.0005
2022-11-14 2022-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 13,961 13,961 223 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.